Sonaphi is a San Francisco based technology start-up which uses vocal biomarkers combined with machine learning to derive valuable insights into health and wellness.
VRI is part of a clinical trial the company is undertaking to establish the efficacy and accuracy of its Covid-19 voice-based screening tool. The project will help provide important data and information to the FDA.
The Sonaphi Voice algorithm extracts vocal features found to be related to the presence of Covid-19. Voice analysis is based on vagal nerve function and the innervation of the vocal cords, modulating the voice according to nerve signals.
Yes. The need for reliable telemedicine data submitted within HIPAA compliance drives the innovation behind Sonaphi. The voice recordings and associated data are analyzed and stored with high level encryption, data protection, and HIPAA compliance.